Navigation Links
Oncogene in Medical News

New oncogene gives valuable insight into hepatocellular tumors in humans

Copenhagen, Denmark, Thursday 23 April: The first identification of GP130 somatic activating mutations* in human tumours was announced today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver Disease in Copenhagen, Denmark. Identification of recurrent somatic m...

Blocking Oncogene Can Stop Spread of Ovarian Cancer

Lab study showed it had effect on 60% Of malignant cells MONDAY, Dec. 15 (HealthDay News) -- Blocking proteins produced by the oncogene MYC can stop the spread of ovarian cancer, researchers say. An oncogene is a gene that has the potential to help cause cancer. In up to 60 perce...

Colon Cancer Oncogene Discovered

CDK8 is frequently amplified in these malignancies, study finds SUNDAY, Sept. 14 (HealthDay News) -- Researchers have identified a new genetic player in the development of colon cancer. The findings implicate CDK8, a protein that regulates gene expression in the proliferation of co...

New Oncogene for Brain Cancer

An overexpressed gene found at the scene of a variety of tumors is implicated in the development of two types of malignant brain cancer in a paper by researchers at The University of Texas M. D. Anderson Cancer Center to be published in the Proceedings of the National Academy of Sciences. Jus...

Pair of MicroRNA Molecules Controls Major Oncogene in Most Common Leukemia

Researchers at Ohio State University have discovered that two microRNA (miRNA) molecules help control the oncogene responsible for a dangerous form of B-cell chronic// lymphocytic leukemia (B-CLL), the most common human leukemia in the world. Their findings, published in the December 15 iss...

Gene Connections Key to Brain Tumor Growth

...ther genes. The hub gene is the EGFR (epidermal growth factor receptor) oncogene on chromosome 7, according to the study. It is amplified in about 45 percen...e researchers reported. A decrease in the function of ANXA7 shoots the EGFR oncogene into overdrive, contributing to the development and progression of maliciou...

Study pinpoints novel cancer gene and biomarker

...iguing as this finding was, it was hardly enough to prove that GOLPH3 is an oncogene -- a contributor to cancer when overexpressed within a cell. Demonstrating ...Harvard Medical School. In addition to identifying GOLPH3 as a bona fide oncogene and an indicator of whether rapamycin is likely to be effective against spe...

Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service

...AS family of cancer-promoting oncogenes, which include KRAS and NRAS , are implicated in several cancers, including colorectal cancer. BRAF is an oncogene of RAF, which is a family of proteins typically activated by RAS and which influence cellular activity. About Quest Diagnostics Quest Diagno...

Cancer cells need normal, nonmutated genes to survive

...a tumor, which deprives cells of oxygen. Survival requires a complete kit of stress response tools. "Researchers often characterize cancer cells as oncogene addicts, but they're just as reliant on normal genes that alleviate stress," explains senior author Stephen Elledge, a professor at HMS and Brigham an...

NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO

...ract # 11034, Sunday, May 31, 2009, 2 p.m. to 6 p.m. Overexpression of an oncogene linked to worse melanoma prognosis Iman Osman, M.D., associate professo...r Institute present preliminary evidence that overabundant expression of an oncogene called Skp2 was associated with a worse melanoma prognosis. The activity of...
Oncogene in Medical Technology

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

...ular therapeutic strategy should be used by oncologists. Most colorectal cancer is caused by somatic mutations and is not hereditary. Mutations in the oncogene KRAS are seen in over 40 percent of sporadic colorectal cancers. While several laboratories in the United States offer this test, ARUP Laboratories'...

Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009

... References Li D et al. "BIBW2992, an irreversible EGFR/HER2 inhibitor highlyeffective in preclinical lung cancer models." oncogene 2008;27:4702-4711 Shih J-Y et al. "A Phase II study of BIBW 2992, a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor (TKI), in...

Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research

...g of Cequent's lead drug candidate Poster CEQ508, an orally administered tkRNAi therapeutic Presentation targeting the primary oncogene (beta-catenin, CTNNB1) in FAP (familial adenomatous polyposis). FAP is an inherited gastrointestinal disea...

Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference

...e CEQ501, an orally administered tk RNAi therapeutic targeting the primary oncogene (beta-catenin, CTNNB1) in FAP (familial adenomatous polyposis). FAP is an i...cer that our tk RNAi technology effectively suppresses beta-catenin, a key oncogene in FAP. These new results are very encouraging, and represent another signi...

Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer

...) HER2 Clinical Rationale The amplification of the HER2-region of chromosome 17 results in the constitutive overexpression of the HER2 oncogene protein and fuels uncontroled tumor growth in approximately 15 to 30% of breast tumors. HER2 is considered today as a predictive marker for clinical b...

Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells

...beneficial for patients with KRAS wild-type tumors, however, show limited or no efficacy in the treatment of colon cancer patients with a mutated KRAS oncogene in their cancer cells. These findings recently led to the approval of cetuximab for first-line therapy in patients with KRAS wild-type tumors. As a co...

Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)

... Phase 2 Study for NKTR-102 Will Target Newly-Identified K-Ras Mutated oncogene Population in Patients with Advanced Colorectal Cancer New Phase 2 Clinica... Meeting shows colorectal cancer (CRC) patients with tumors that have K-Ras oncogene mutations (K-Ras mutant types) do not respond to EGFR-inhibitors, such as c...

Use of Sequenom's MassARRAY System Leads to Significant Scientific Advances in Understanding Cancer, Diabetes and Drug-Resistant Malaria

...ighly recognized peer-reviewed journals as follows: -- In "High-Throughput oncogene Mutation Profiling in Human Cancer," published in the February issue of Nat...nsitivity and scalability, utilized MassARRAY technology to assay 238 known oncogene mutations across 1,000 human tumor samples. The results enable researchers ...

News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics

...nt of genetic medicine with the development and commercialization of its proprietary targeted delivery systems. Credited with innovations ranging from oncogene discovery, to designer therapeutic genes, to pathotropic (disease-seeking) targeting, to high-performance vector engineering, to advanced biopharmaceu...

Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy

...eu as a serum marker. This bypasses the need for a tissue specimen and may allow earlier Her-2/neu detection. The Her-2/neu ELISA (Bayer Diagnostics oncogene Science) is a sandwich-type immunoassay approved to monitor patients with known metastatic breast cancer. With other methods such as RT-PCR on t...
Oncogene in Biological News

Fox Chase researchers uncover one force behind the MYC oncogene in many cancers

Philadelphia (July 27, 2009) DLX5, a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers from Fox Chase Cancer Center. Since the DLX5 gene is inactive in normal adults, it may be an ideal target for future anti-...

High-throughput oncogene mutation detection in human cancers by mass spectrometry-based genotyping

Researchers have devised a new method to detect a spectrum of known gene mutations in a variety of cancer genes that they say is both sensitive and cost-effective. They say that if validated, this method of genotyping might ultimately be used in "real time" to match patients to available targeted t...

Pair of microRNA molecules controls major oncogene in most common leukemia

Researchers at Ohio State University have discovered that two microRNA (miRNA) molecules help control the oncogene responsible for a dangerous form of B-cell chronic lymphocytic leukemia (B-CLL), the most common human leukemia in the world. Their findings, published in the December 15 issue of C...

Protein identified as critical to insulating the body's wiring could also become treatment target

... and Charcot-Marie-Tooth neuropathy, a genetic, progressive disease that weakens muscles. Cancer is an issue because the ErbB2 receptor also is an oncogene highly expressed in tumors. ErbB2 helps cancer cells grow and spread so finding its role in the receptor's stability and function provides a potential...

CSHL team develops mouse models of leukemia that predict response to chemotherapy

...tions identified by Lowe's team in AML patients have been well studied. The oncogene AML1/ETO previously has been associated with a favorable therapeutic outcom...be correct. Just as in humans, leukemias in mice that received the AML1/ETO oncogene were also sensitive to chemotherapy and soon regressed, whereas MLL-trigger...

Skin cancer study uncovers new tumor suppressor gene

...led to slow -- and in some cases even sped up -- tumor growth. Now, it turns out that one of the most often mutated MMP genes in melanoma is not an oncogene at all. In its study, the team led by researchers from the National Human Genome Research Institute (NHGRI) found that MMP-8 actually serves as a tumo...

Small molecules block cancer gene

... HOUSTON (March 10, 2009) Finding molecules that block the activity of the oncogene Stat 3 (signal transducer and activator of transcription) required screening literally millions of compounds, using computers that compared the struct...

NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis

...und a miRNA is over-expressed in metastatic melanoma cell lines and tissues. The lab found that the elevated expression of miRNA 182 turns it into an oncogene (a gene involved in cancer tumor initiation or progression), by increasing the invasive capacity of melanoma cells in vitro and stimulating the cell's...

Cancer-causing gene discovery suggests new therapies

...r on the paper with Barna. "The ability of the Myc oncogene to directly alter this process may well explain th... in DNA activity in the cell nucleus. But how the oncogene affected the subsequent production of proteins, a ...ne that was cancer-prone and overexpressed the Myc oncogene and one that was newly engineered to lower protein...

Festschrift Issue honoring Judah Folkman, M.D. in Lymphatic Research and Biology

...e Lymphangiogenesis?," Yihai Cao explains the processes behind increased lymphatic supply to cancerous lesions. Dean Felsher explores the phenomena of oncogene addiction, cellular senescence, and the angiogenic switch in a report entitled, "Reversing Cancer From Inside and Out." In a forward-looking review, S...
Oncogene in Biological Technology

EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference

TARRYTOWN, N.Y., Oct. 15 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Dr. John Drewe, Senior Director of Lead Discovery, will be presenting at the IBC conference on Assays and Cellular Targets at the Hotel Del Coronado in San Diego, ...

Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases

...house IBD program. "While we are furthest along with our drug candidate CEQ508, an orally administered tk RNAi therapeutic targeting the primary oncogene (beta-catenin, CTNNB1) in FAP (familial adenomatous polyposis) -- our IBD program is actually the company's largest, and Stephen has been critical to ...

NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer

...ject in ovarian cancer. For the first phase of the project, the group will use a biologically-driven approach to characterize gene expression and oncogene activation of copy number and point mutations in preclinical models by profiling ovarian cancer cells and ovarian cancer stem cells. The consortium wi...

Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology

...mphangiogenesis?," Yihai Cao explains the processes behind increased lymphatic supply to cancerous lesions. Dean Felsher explores the phenomena of oncogene addiction, cellular senescence, and the angiogenic switch in a report entitled, "Reversing Cancer From Inside and Out." In a forward-looking review, ...

Oncomine(TM) Again Key to Prostate Cancer Discovery

...Ph.D., in his continued role as a research investigator at the University of Michigan, led the Oncomine analysis that identified SPINK1 as a candidate oncogene in prostate cancer. Further experimental work by many of the same scientists that previously identified ETS-family gene fusions in prostate cancer usi...

Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets

...of ORD has the potential to generate new opportunities to improve cancer care." About Our Compound Targets Human Double Minute 2 (Hdm2) The Hdm2 oncogene is activated in cancers through various mechanisms, including gene amplification and deletion of upstream tumor suppressors. Hdm2 over-expression indu...

Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference

... proto- oncogenes (abstract C175). This establishes EpCAM as a signal transducer of cancer cells and explains how EpCAM induces cell proliferation and oncogene expression. EpCAM is found widely expressed on human cancers and is also found on so called 'cancer stem cells' from colon, pancreas, prostate and bre...

Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings

...ct C175). These data not only establish EpCAM as a signal transducer of cancer cells, but could explain how the protein induces cell proliferation and oncogene expression, and support a critical role of EpCAM in cancer stem cell regulation. "All of these new findings correlate well together and highlight the...

New Insights Into DNA Decontamination

...tion of mouse skin endothelial cells in vivo by direct application of plasmid DNA encoding the human T24 H-ras oncogene. oncogene 6(11), 1973-1978. ...

Research Tools for Analysis of ZAP-70

... References 1. Palacios, E.H. and Weiss, A. (2004) Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. oncogene 23:7990-8000. 2. Abraham, R.T. and Weiss, A. (2004) Jurkat T cells and development of the T-cell receptor signalling paradigm. Nature Rev...
Oncogene in Biological Products

Rabbit Anti-Human RAB32 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Description:... RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Company:Proteintech Group, Inc.
Oncogene in Biological Definition

Oncogene

An oncogene is a gene that can cause a cell to develop into a tumor cell, possibly resulting in cancer . Contents showTocToggle("show","hide") 1 Protooncogene 1.1 Activation 2 Oncogene 2.1 Growth factors 2.2 Protein kinases and related proteins ...

Cancer

...mutations in both types of genes are necessary, as a mutation limited to an oncogene would be suppressed by normal mitosis control. Mutations can have various... retroviruses , herpesviruses and papillomaviruses , usually carry some oncogene or tumor suppressor inactivating gene in their genome . It is impossible...
Oncogene in Biological Dictionary

Oncogene

An oncogene is a gene that, when mutated or expressed at high levels, helps turn a normal cell into a cancer cell. genetic material that carries the ability to induce cancer. An oncogene is a sequence of deoxyribonucleic acid (DNA) that has been altered or mutated from its original...

Viral oncogene

If the viral LTRs are close enough to that oncogene , they will upregulate ... called viral - oncogene (v-onc), and the infected cell is transformed as soon as ... v-rel reticuloendotheliosis viral oncogene homolog (avian), also known as REL, is a human gene. The protein ...

Transversion

...on: Discuss topics of TransVersion ) - this ... ... efficiently extended implicating O2-Et-dT in transversion mutagenesis in vivo. ... of the oncogene neu by an A.T----T.A transversion event in rat neuroblastomas. ... The promoter sequence having this transversion has a higher promoter ...

Trans-splicing

...se specialized trans - splicing reactions are very efficient. In mammals, however, trans - splicing of conventional pre-mRNAs appears to be ... oncogene is one of the world's leading cancer journals. ... In mammals, trans - splicing can be used to reprogram or interfere with specific ... Trans ...

Proto-oncogene

... An oncogene is a gene that, when mutated or expressed at hi...l cell into a cancer cell. The RET proto - oncogene encodes a receptor tyrosine kinase for member...with the... ... of this gene is "ret proto - oncogene ." RET is the gene's official symbol. ... ret pro...

MicroRNA

... and cancer. Human gene count drops again ... MicroRNA . Diophantine equations. Cytokine storms ... Pair Of MicroRNA Molecules Controls Major oncogene In Most Common Leukemia (12 ... Labels: cancer, let-7, microRNA , Myc, news dump, stem cells ... He also presents recent discoveries in the m...

G2 phase

...al chromatids), the cell moves onto the G2 phase . G2 Phase ... oncogene is one of the world's leading cancer journals. ... Once induced in G2 ... D1 expression became Ras independent through the next G1 phase . ... oncogene is one of the world's leading cancer journals. ... UV radiation causes bo...

AP-1

...ted Press ( AP ), and the Bowl Championship Series (BCS) ... AP Top 25. Rankings Not Available. USA Today Poll. 1 . Florida (53) 0-0 1 ,466 ... oncogene is one of the world's leading cancer journals. ... Upon induction, TAM-67 was expressed and AP - 1 activity was inhibited in these cells. ... S...

Amino Terminus

...es the acetylationof of lysines in preparation for mass ... After acetylation the amino terminus of the protein should be modified giving ... oncogene is one of the world's leading cancer journals. ... The cytoplasmic amino - terminus provides the structural information whereby ... The polype...
Other Tags
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... Miami, FL (PRWEB) December 25, 2014 When ... often find themselves in a frenzy to get rid of ... classroom. But families in Coral Gables now have the solution ... its second salon clinic location, Lice Troopers provides full spectrum ... in the Coral Gable area, including Sunset, Key Biscayne, Brickell, ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
(Date:12/25/2014)... 25, 2014 Thousands of transvaginal mesh ... in a number of multidistrict litigations currently underway in ... Liebhard LLP reports. According to an Order issued on ... a Joint Status Conference in all of the proceedings ... been directed to submit a proposed agenda to the ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the addition of the "The Global ... their offering. ... an overview of the global digital media ... control and monitor piracy by securely and ...
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
Other Contents